1-Minute Consult

What is the role of roflumilast in chronic obstructive pulmonary disease?

Chris Lau, MD, Atul C. Mehta, MD and Umur Hatipoglu, MD
Cleveland Clinic Journal of Medicine January 2017, 84 (1) 13-15; DOI: https://doi.org/10.3949/ccjm.84a.15150

Article Figures & Data

Tables

  • TABLE 1

    Studies discussed in this article

    AURA
    Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-124)5
    EOS
    Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease Patients Treated With Salmeterol (BY217/M2-127)4
    HELIOS
    Effect of Roflumilast in Chronic Obstructive Pulmonary Disease) Patients Treated With Tiotropium (BY217/M2-128)4
    HERMES
    Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-125)5
    RATIO
    Effect of 1-Year Treatment With Roflumilast in Severe Chronic Obstructive Pulmonary Disease3
    REACT
    Effect Of Roflumilast On Exacerbations In Patients With Severe Chronic Obstructive Pulmonary Disease Uncontrolled By Combination Therapy: A Multicentre Randomised Controlled Trial6
    RECORD
    Roflumilast—An Oral Anti-inflammatory Treatment for Chronic Obtructive Pulmonary Disease: A Randomised Controlled Trial1
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Subjects